Rebuilding After Sa...
Health Care: Drugs
Actavis Inc (ACT: NYSE)
$130.04 -0.16 | -0.12%
05/22/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with ACT
- Portfolio NameUser Type
- ContributorHigh Volume Technicals for ...
- ContributorHigh Volume Technicals for ...
Latest ACT Headlines from TheStreet
- The Deal: Actavis Extends Gains Following Warner Deal 05.21.13 | 03:05 pm
- Stocks Slip on Concerns Markets Overpriced 05.20.13 | 04:05 pm
- Ireland Welcomes Watson Pharmaceuticals, an American Success 05.20.13 | 02:05 pm
- The Deal: Actavis Plays Hunter in $8.5 Billion Deal for Ireland's Warner Chilcott 05.20.13 | 10:05 am
- Actavis Stock Hits New 52-Week High (ACT) 05.20.13 | 09:05 am
- Futures Slip as Investors Seek Fed Clarity 05.20.13 | 09:05 am
- 4 Stocks Improving Performance Of The Health Care Sector 05.16.13 | 01:05 pm
- Morning Briefing: 10 Things You Should Know 05.16.13 | 07:05 am
- Actavis Inc (ACT): Today's Featured Health Care Winner 05.15.13 | 05:05 pm
- Actavis Rises On Unusually High Volume (ACT) 05.14.13 | 02:05 pm
Press Releases for ACT
- Actavis To Acquire Warner Chilcott To Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company - PR Newswire 05.20.13 | 07:05 am
- Announcement Under Irish Takeover Rules Relevant Securities In Issue - PR Newswire 05.14.13 | 01:05 am
- Actavis Acquires Worldwide Rights For Valeant's Metronidazole 1.3% Vaginal Gel - PR Newswire 05.01.13 | 08:05 am
- Actavis Acquires Worldwide Rights For Valeant's Metronidazole 1.3% Vaginal Gel - PR Newswire 05.01.13 | 08:05 am
- Actavis Reaches Agreement With Shire To Launch A Generic Version Of Intuniv® In December 2014 - PR Newswire 04.25.13 | 09:04 am
- Actavis Reaches Agreements With Valeant To Launch Generic Versions Of Ziana® And Zyclara® - PR Newswire 04.10.13 | 08:04 am
- Actavis Reaches Agreements With Valeant To Launch Generic Versions Of Ziana® And Zyclara® - PR Newswire 04.10.13 | 08:04 am
- Actavis And Valeant Announce Actavis As Exclusive Authorized Generic Marketer Of Zovirax® Ointment; Co-Promotion Agreements On Zovirax® Cream And Cordran® Tape - PR Newswire 04.05.13 | 08:04 am
- Actavis And Valeant Announce Actavis As Exclusive Authorized Generic Marketer Of Zovirax® Ointment; Co-Promotion Agreements On Zovirax® Cream And Cordran® Tape - PR Newswire 04.05.13 | 08:04 am
- Actavis Confirms Court Issues TRO Related To Generic Pulmicort RESPULES® Distribution - PR Newswire 04.03.13 | 06:04 am
Partner Headlines for ACT
- AstraZeneca loses US drug patent judgment - Financial Times 04.02.13 | 10:04 am
- Aetna Offloads Business and 4 Stocks At 52-Week Highs - Wall St. Cheat Sheet 04.02.13 | 09:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 'Pay For Delay' Case Could Change Generic Drug Rules - Investor's Business Daily 03.26.13 | 04:03 pm
